AbClon Revises Supply Contract with MFDS National Institute for 355.8 Million KRW, Contract Amount Reduced by 10.2%
AbClon has filed a correction to its voluntary disclosure regarding a single sale and supply contract with the MFDS National Institute of Food and Drug Safety Evaluation, originally announced on April 7, 2026.
The contract amount has been adjusted downward from 396.3 million KRW to 355.8 million KRW, a reduction of approximately 10.2%, due to a contract modification.
The contract is for supplying reagents and lab equipment, representing 7.5% of AbClon's 2025 individual revenue of 4.71 billion KRW. The contract period runs from April 16 to June 30, 2026, with payment upon delivery.
This is a routine government procurement contract awarded through the national bidding system KONEPS, with no conditional clauses or upfront payments.
[AI Summary]AbClon's correction disclosure shows a decrease in contract value but the counterparty is a highly credible government agency. This is a standard operational contract with no dilution or strategic capital allocation impact, therefore neutral for shareholder value.
KOSDAQ Filing Information
[Correction Of Description] Conclusion Of Single Sales And Supply Agreement (Voluntary Disclosure)